Home » Health » RMTC: Volume 50-6, June 2024: Anti-Cancer Vaccines

RMTC: Volume 50-6, June 2024: Anti-Cancer Vaccines

2024-06-28 19:46:13

Table of contents

Preview

Reducing the potential effectiveness, actual effectiveness, and immunogenicity of HPV vaccination programs: a review of existing evidence
J Montroy, MI Salvadori, N Forbes, V Dubey, S Almasri, A Jirovec, C Yan, K Gusic, A Stevens, K Young, M Tunis

monitor

Healthcare-associated infections and antimicrobial resistance in acute care hospitals in Canada, 2018-2022
Canadian Hospital Infection Surveillance Program

Infections associated with medical devices and surgical procedures in acute care hospitals in Canada, 2018-2022
Canadian Hospital Infection Surveillance Program

scoping review

Topic description of factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae in humans
J. Goltz, C. Ulan, S. Pierce, C. Murphy, C. Carson, J. Parmley

epidemiological research

Characteristics associated with SARS-CoV-2 screening, infection, and vaccination rates among non-healthcare essential workers in Montreal, 2021
C Kaya, D Menzies, J Papenburg, C Jansuni, J Campbell

1724562137
#RMTC #Volume #June #AntiCancer #Vaccines

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Adblock Detected

Please support us by disabling your AdBlocker extension from your browsers for our website.